National Center for Health Statistics. Health, United States, 2010: With Special Feature on Death and Dying. (U.S. Government) (2011)

Kanth P, Grimmett J, Champine M, Burt R, Samadder NJ (2017) Hereditary colorectal polyposis and cancer syndromes: a primer on diagnosis and management. Am J Gastroenterol 112(10):1509–1525

Article  PubMed  Google Scholar 

Rho JH, Ladd JJ, Li CI et al (2018) Protein and glycomic plasma markers for early detection of adenoma and colon cancer. Gut 67(3):473–484

Article  CAS  PubMed  Google Scholar 

Ivancic MM, Irving AA, Jonakin KG, Dove WF, Sussman MR (2014) The concentrations of EGFR, LRG1, ITIH4, and F5 in serum correlate with the number of colonic adenomas in ApcPirc/+ rats. Cancer Prev Res (Phila) 7(11):1160–1169

Article  CAS  PubMed  Google Scholar 

Schmelz EM, Xu H, Sengupta R et al (2007) Regression of early and intermediate stages of colon cancer by targeting multiple members of the EGFR family with EGFR-related protein. Cancer Res 67(11):5389–5396

Article  CAS  PubMed  Google Scholar 

Fichera A, Little N, Jagadeeswaran S et al (2007) Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis. Cancer Res 67(2):827–835

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roberts RB, Min L, Washington MK et al (2002) Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis. Proc Natl Acad Sci USA 99(3):1521–1526

Article  CAS  PubMed  PubMed Central  Google Scholar 

Torrance CJ, Jackson PE, Montgomery E et al (2000) Combinatorial chemoprevention of intestinal neoplasia. Nat Med 6(9):1024–1028

Article  CAS  PubMed  Google Scholar 

Gillen DL, Meyskens FL, Morgan TR et al (2015) A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum. Cancer Prev Res (Phila) 8(3):222–230

Article  CAS  PubMed  Google Scholar 

Giardiello FM, Yang VW, Hylind LM et al (2002) Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med 346(14):1054–1059

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asano TK, McLeod RS (2004) Non steroidal anti-inflammatory drugs (NSAID) and Aspirin for preventing colorectal adenomas and carcinomas. Cochrane Database Syst Rev (2):Cd004079

Cruz-Correa M, Hylind LM, Romans KE, Booker SV, Giardiello FM (2002) Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology 122(3):641–645

Article  CAS  PubMed  Google Scholar 

Samadder NJ, Neklason DW, Boucher KM et al (2016) Effect of sulindac and erlotinib vs placebo on duodenal neoplasia in familial adenomatous polyposis: a randomized clinical trial. JAMA 315(12):1266–1275

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samadder NJ, Kuwada SK, Boucher KM et al (2018) Association of sulindac and erlotinib vs placebo with colorectal neoplasia in familial adenomatous polyposis: secondary analysis of a randomized clinical trial. JAMA Oncol 4(5):671–677

Article  PubMed  PubMed Central  Google Scholar 

Burn J, Gerdes AM, Macrae F et al (2011) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378(9809):2081–2087

Article  PubMed  PubMed Central  Google Scholar 

Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW (2011) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 377(9759):31–41

Article  CAS  PubMed  Google Scholar 

Sato T, Vries RG, Snippert HJ et al (2009) Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459(7244):262–265

Article  CAS  PubMed  Google Scholar 

Sato T, Stange DE, Ferrante M et al (2011) Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology 141(5):1762–1772

Article  CAS  PubMed  Google Scholar 

Fujii M, Shimokawa M, Date S et al (2016) A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell 18(6):827–838

Article  CAS  PubMed  Google Scholar 

Bongers G, Muniz LR, Pacer ME et al (2012) A role for the epidermal growth factor receptor signaling in development of intestinal serrated polyps in mice and humans. Gastroenterology 143(3):730–740

Article  CAS  PubMed  Google Scholar 

Sakamoto N, Feng Y, Stolfi C et al (2017) BRAF(V600E) cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis. eLife 6

Delker DA, Wood AC, Snow AK et al (2018) Chemoprevention with cyclooxygenase and epidermal growth factor receptor inhibitors in familial adenomatous polyposis patients: MRNA signatures of duodenal neoplasia. Cancer Prev Res (Phila) 11(1):4–15

Article  CAS  PubMed  Google Scholar 

Kanth P, Bronner MP, Boucher KM et al (2016) Gene signature in sessile serrated polyps identifies colon cancer subtype. Cancer Prev Res (Phila) 9(6):456–465

Article  CAS  PubMed  Google Scholar 

Fujii M, Matano M, Nanki K, Sato T (2015) Efficient genetic engineering of human intestinal organoids using electroporation. Nat Protoc 10(10):1474–1485

Article  CAS  PubMed  Google Scholar 

Schell JC, Wisidagama DR, Bensard C et al (2017) Control of intestinal stem cell function and proliferation by mitochondrial pyruvate metabolism. Nat Cell Biol 19(9):1027–1036

Article  CAS  PubMed  PubMed Central  Google Scholar 

Williams CS, Goldman AP, Sheng H, Morrow JD, DuBois RN (1999) Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth. Neoplasia 1(2):170–176

Article  CAS  PubMed  PubMed Central  Google Scholar 

Herrmann C, Block C, Geisen C et al (1998) Sulindac sulfide inhibits Ras signaling. Oncogene 17(14):1769–1776

Article  CAS  PubMed  Google Scholar 

Weickhardt AJ, Price TJ, Chong G et al (2012) Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: preclinical evaluation and results of the phase II DUX study in chemotherapy-refractory, advanced colorectal cancer. J Clin Oncol 30(13):1505–1512

Article  CAS  PubMed  Google Scholar 

Kanth P, Boylan KE, Bronner MP et al (2019) Molecular biomarkers of sessile serrated adenoma/polyps. Clin Transl Gastroenterol 10(12):e00104

Article  PubMed  PubMed Central  Google Scholar 

Kim B, Giardiello FM (2011) Chemoprevention in familial adenomatous polyposis. Best Pract Res Clin Gastroenterol 25(4–5):607–622

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lannagan TRM, Lee YK, Wang T et al (2019) Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis. Gut 68(4):684–692

Article  CAS  PubMed  Google Scholar 

Fessler E, Drost J, van Hooff SR et al (2016) TGFbeta signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype. EMBO Mol Med 8(7):745–760

Article  CAS  PubMed  PubMed Central  Google Scholar 

Delker DA, McGettigan BM, Kanth P et al (2014) RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers. PLoS ONE 9(2):e88367

Article  PubMed  PubMed Central  Google Scholar 

Nesbit CE, Tersak JM, Prochownik EV (1999) MYC oncogenes and human neoplastic disease. Oncogene 18(19):3004–3016

Article  CAS  PubMed  Google Scholar 

Topham C, Tighe A, Ly P et al (2015) MYC is a major determinant of mitotic cell fate. Cancer Cell 28(1):129–140

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pignatelli M (1999) The adenomatous polyposis coli tumour suppressor gene regulates c-MYC transcription in colon cancer cells. Gut 44(5):596

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vaish V, Piplani H, Rana C, Vaiphei K, Sanyal SN (2013) NSAIDs may regulate EGR-1-mediated induction of reactive oxygen species and non-steroidal anti-inflammatory drug-induced gene (NAG)-1 to initiate intrinsic pathway of apoptosis for the chemoprevention of colorectal cancer. Mol Cell Biochem 378(1–2):47–64

Article  CAS  PubMed  Google Scholar